Literature DB >> 5551484

Clinical significance of plasma imipramine levels.

C J Walter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5551484      PMCID： PMC1811504     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  22 in total

1.  Time-out from positive reinforcement.

Authors:  N H AZRIN
Journal:  Science       Date:  1961-02-10       Impact factor: 47.728

2.  Imperfection: biochemical phobias and metabolic ambivalence.

Authors:  D L DRABKIN
Journal:  Perspect Biol Med       Date:  1959       Impact factor: 1.416

3.  Treatment of depression. A comparative trial of imipramine and desipramine.

Authors:  J T Rose; T T Westhead
Journal:  Br J Psychiatry       Date:  1967-06       Impact factor: 9.319

4.  Comparison of the effect of imipramine and desipramine on some symptoms of depressive illness.

Authors:  G Edwards
Journal:  Br J Psychiatry       Date:  1965-09       Impact factor: 9.319

5.  The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine.

Authors:  M H Bickel; H J Weder
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-06

6.  A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man.

Authors:  W Hammer; S Mårtens; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1969 Jan-Feb       Impact factor: 6.875

7.  Plasma levels of imipramine and desmethylimipramine during therapy.

Authors:  J P Moody; A C Tait; A Todrick
Journal:  Br J Psychiatry       Date:  1967-02       Impact factor: 9.319

8.  Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.

Authors:  W Hammer; F Sjöqvist
Journal:  Life Sci       Date:  1967-09-01       Impact factor: 5.037

9.  Methylation of desmethylimipramine by rabbit lung in vitro.

Authors:  J V Dingell; E Sanders
Journal:  Biochem Pharmacol       Date:  1966-05       Impact factor: 5.858

10.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27
View more
  11 in total

1.  The relationship between nortriptyline plasms levels and clinical effects.

Authors:  P Kragh-Sorensen
Journal:  Proc R Soc Med       Date:  1975-02

2.  The assessment of interactions in man between tyramine and viloxazine hydrochloride, an antidepressant drug.

Authors:  K Ghose; P Turner; I N Grant
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

3.  Plasma concentrations of tricyclic antidepressive drugs.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

4.  The significance of drug interactions in the evaluation of psychotropic drugs.

Authors:  R A Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 5.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 6.  Clinical use of psychotherapeutic drugs. II. Antidepressant and antianxiety drugs and special problems in the use of psychotherapeutic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

7.  Plasma levels of imipramine and desipramine in man after different routes of administration.

Authors:  A Nagy; R Johansson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 8.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

9.  Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.

Authors:  P Kragh-Sorensen; C E Hansen; P C Baastrup; E F Hvidberg
Journal:  Psychopharmacologia       Date:  1976-02-02

10.  Pharmacokinetic study of zimelidine using a new GLC method.

Authors:  G Caillé; E Kouassi; C de Montigny
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.